Towa Pharmaceutical Co., Ltd. (TYO: 4553)
Japan
· Delayed Price · Currency is JPY
3,220.00
-60.00 (-1.83%)
Jan 15, 2025, 3:45 PM JST
Towa Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | 24,367 | 24,459 | 4,605 | 22,246 | 18,728 | 20,709 | Upgrade
|
Depreciation & Amortization | 18,830 | 17,888 | 19,409 | 10,954 | 10,425 | 8,285 | Upgrade
|
Loss (Gain) From Sale of Assets | -63 | -225 | 478 | -96 | -97 | 6 | Upgrade
|
Loss (Gain) From Sale of Investments | -18 | -18 | 19 | 5 | -17 | 1 | Upgrade
|
Other Operating Activities | -8,303 | -1,036 | -5,910 | -4,437 | -5,803 | -6,590 | Upgrade
|
Change in Accounts Receivable | -948 | -15,523 | -1,592 | 441 | -4,544 | 2,776 | Upgrade
|
Change in Inventory | -5,471 | -6,288 | -18,496 | -7,950 | -9,707 | -4,301 | Upgrade
|
Change in Accounts Payable | -427 | -10,509 | 6,554 | 3,675 | 2,451 | 1,826 | Upgrade
|
Change in Other Net Operating Assets | -6,577 | -536 | -2,523 | -2,709 | 572 | -3,548 | Upgrade
|
Operating Cash Flow | 21,390 | 8,212 | 2,544 | 22,129 | 12,008 | 19,164 | Upgrade
|
Operating Cash Flow Growth | - | 222.80% | -88.50% | 84.29% | -37.34% | 0.85% | Upgrade
|
Capital Expenditures | -31,372 | -37,851 | -28,731 | -11,140 | -9,137 | -4,549 | Upgrade
|
Sale of Property, Plant & Equipment | 1 | 1 | 239 | 42 | 3 | - | Upgrade
|
Cash Acquisitions | -1,570 | -1,570 | - | -45,405 | -894 | -37,710 | Upgrade
|
Sale (Purchase) of Intangibles | -1,786 | -1,055 | -1,723 | -2,353 | -501 | -121 | Upgrade
|
Investment in Securities | -50 | -50 | -267 | 17 | - | 4,860 | Upgrade
|
Other Investing Activities | -247 | 131 | 198 | -220 | 205 | 109 | Upgrade
|
Investing Cash Flow | -35,024 | -40,394 | -30,284 | -59,729 | -9,100 | -39,541 | Upgrade
|
Short-Term Debt Issued | - | - | - | 47,135 | - | 20,200 | Upgrade
|
Long-Term Debt Issued | - | 46,935 | 78,831 | 9,160 | 40,500 | - | Upgrade
|
Total Debt Issued | 38,874 | 46,935 | 78,831 | 56,295 | 40,500 | 20,200 | Upgrade
|
Short-Term Debt Repaid | - | -768 | -45,680 | - | -20,251 | - | Upgrade
|
Long-Term Debt Repaid | - | -7,607 | -12,268 | -7,181 | -17,745 | -6,396 | Upgrade
|
Total Debt Repaid | -11,984 | -8,375 | -57,948 | -7,181 | -37,996 | -6,396 | Upgrade
|
Net Debt Issued (Repaid) | 26,890 | 38,560 | 20,883 | 49,114 | 2,504 | 13,804 | Upgrade
|
Issuance of Common Stock | - | - | - | 21 | - | 12 | Upgrade
|
Dividends Paid | -2,899 | -2,952 | -3,100 | -2,411 | -2,166 | -2,067 | Upgrade
|
Other Financing Activities | 4,490 | -201 | -302 | -184 | -154 | -1 | Upgrade
|
Financing Cash Flow | 28,481 | 35,407 | 17,481 | 46,540 | 184 | 11,748 | Upgrade
|
Foreign Exchange Rate Adjustments | 2,225 | 2,167 | 1,685 | 975 | 761 | 689 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 213 | 1 | 1 | - | 348 | 2 | Upgrade
|
Net Cash Flow | 17,285 | 5,393 | -8,573 | 9,915 | 4,201 | -7,938 | Upgrade
|
Free Cash Flow | -9,982 | -29,639 | -26,187 | 10,989 | 2,871 | 14,615 | Upgrade
|
Free Cash Flow Growth | - | - | - | 282.76% | -80.36% | 85.97% | Upgrade
|
Free Cash Flow Margin | -4.09% | -13.00% | -12.54% | 6.64% | 1.85% | 13.24% | Upgrade
|
Free Cash Flow Per Share | -202.80 | -602.17 | -532.02 | 218.36 | 55.99 | 274.85 | Upgrade
|
Cash Interest Paid | 1,262 | 941 | 610 | 226 | 172 | 130 | Upgrade
|
Cash Income Tax Paid | 8,556 | 1,760 | 6,285 | 4,748 | 6,231 | 6,871 | Upgrade
|
Levered Free Cash Flow | -10,572 | -32,622 | -27,055 | -1,466 | 2,521 | -1,378 | Upgrade
|
Unlevered Free Cash Flow | -9,752 | -32,030 | -26,658 | -1,322 | 2,640 | -1,296 | Upgrade
|
Change in Net Working Capital | 8,648 | 22,042 | 19,060 | 10,369 | 10,603 | 15,018 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.